DE69841322D1 - Hepatitis c rezeptorprotein cd81 - Google Patents

Hepatitis c rezeptorprotein cd81

Info

Publication number
DE69841322D1
DE69841322D1 DE69841322T DE69841322T DE69841322D1 DE 69841322 D1 DE69841322 D1 DE 69841322D1 DE 69841322 T DE69841322 T DE 69841322T DE 69841322 T DE69841322 T DE 69841322T DE 69841322 D1 DE69841322 D1 DE 69841322D1
Authority
DE
Germany
Prior art keywords
hepatitis
receptor protein
protein
diagnosis
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69841322T
Other languages
English (en)
Inventor
Sergio Abrignani
Guido Grandi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Novartis Vaccines and Diagnostics SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9721182.5A external-priority patent/GB9721182D0/en
Priority claimed from GBGB9813560.1A external-priority patent/GB9813560D0/en
Application filed by Novartis Vaccines and Diagnostics SRL filed Critical Novartis Vaccines and Diagnostics SRL
Application granted granted Critical
Publication of DE69841322D1 publication Critical patent/DE69841322D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
DE69841322T 1997-10-06 1998-10-06 Hepatitis c rezeptorprotein cd81 Expired - Lifetime DE69841322D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9721182.5A GB9721182D0 (en) 1997-10-06 1997-10-06 Hepatitis C receptor protein
GBGB9813560.1A GB9813560D0 (en) 1998-06-23 1998-06-23 Hepatitis C Receptor Protein
PCT/IB1998/001628 WO1999018198A1 (en) 1997-10-06 1998-10-06 Hepatitis c receptor protein cd81

Publications (1)

Publication Number Publication Date
DE69841322D1 true DE69841322D1 (de) 2010-01-07

Family

ID=26312375

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69841322T Expired - Lifetime DE69841322D1 (de) 1997-10-06 1998-10-06 Hepatitis c rezeptorprotein cd81

Country Status (13)

Country Link
US (4) US7097987B2 (de)
EP (1) EP1021534B1 (de)
JP (3) JP4198882B2 (de)
AT (1) ATE449847T1 (de)
AU (1) AU9363398A (de)
CA (1) CA2304796C (de)
CY (1) CY1109868T1 (de)
DE (1) DE69841322D1 (de)
DK (1) DK1021534T3 (de)
ES (1) ES2334727T3 (de)
HK (1) HK1025793A1 (de)
PT (1) PT1021534E (de)
WO (1) WO1999018198A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113914A1 (en) * 2001-12-10 2003-06-19 Isis Pharmaceuticals, Inc. Antisense modulation of CD81 expression
US20020160936A1 (en) * 1999-09-29 2002-10-31 Howard J. Worman Hcv e2 protein binding agents for treatment of hepatitis c virus infection
GB9927320D0 (en) 1999-11-18 2000-01-12 Chiron Spa Exosome separation
EP1245236A4 (de) * 1999-12-28 2004-09-22 Sumitomo Pharma Prophylaktika und therapeutika zur behandung von chronischer hepatitis
CN100391469C (zh) * 2000-02-14 2008-06-04 三菱制药株式会社 丙型肝炎治疗药
JP2001299140A (ja) * 2000-04-24 2001-10-30 Sumitomo Pharmaceut Co Ltd Ｈｃｖを増幅しうる細胞及び非ヒト動物
GB0016361D0 (en) * 2000-07-03 2000-08-23 Chiron Spa Structure-based HCV drug design
WO2002061085A2 (en) * 2000-10-31 2002-08-08 Ryan James W Isolated genomic polynucleotide fragments from the p15 region of chromosome 11
US20030013081A1 (en) 2001-06-26 2003-01-16 Olson William C. Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
JP4221292B2 (ja) * 2001-08-10 2009-02-12 田辺三菱製薬株式会社 Ｃ型肝炎治療薬
WO2005021792A1 (ja) * 2003-08-28 2005-03-10 Dainippon Sumitomo Pharma Co., Ltd. 抗ｃｄ８１抗体を有効成分として含有する炎症性腸疾患の予防または治療剤
TW200813086A (en) * 2006-05-11 2008-03-16 Hoffmann La Roche Immunereconstituted mouse
NL2001318C2 (nl) 2008-02-25 2009-08-26 Schuitemaker Mach Bv Inrichting en werkwijze voor het snijden van kuilvoer.
WO2012107589A1 (en) 2011-02-11 2012-08-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment and prevention of hcv infections
CA2860163A1 (en) * 2011-12-26 2013-07-04 Shionogi & Co., Ltd. Monoclonal antibody for detecting exosomes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3886363T3 (de) 1987-11-18 2004-09-09 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville NANBV-Diagnostika
US5631407A (en) * 1989-03-10 1997-05-20 The Trustees Of Columbia University In The City Of New York Transgenic mouse expressing DNA sequences encoding the human poliovirus receptor
KR0185373B1 (ko) 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
WO1991007489A1 (en) * 1989-11-22 1991-05-30 Childrens Hospital Of Los Angeles Bcr/abl transgenic animals as models for philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia
GB9416671D0 (en) 1994-08-17 1994-10-12 Biocine Spa Assay
GB9517926D0 (en) 1995-09-01 1995-11-01 Biocine Spa Binding protein
US6031088A (en) * 1996-05-23 2000-02-29 Albert Einstein College Of Medicine Of Yeshiva University Polycystic kidney disease PKD2 gene and uses thereof
US7491865B2 (en) * 2004-08-19 2009-02-17 Fred Hutchinson Cancer Research Center Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene

Also Published As

Publication number Publication date
JP2009035553A (ja) 2009-02-19
DK1021534T3 (da) 2010-02-01
US7097987B2 (en) 2006-08-29
WO1999018198A1 (en) 1999-04-15
CA2304796C (en) 2013-12-03
PT1021534E (pt) 2010-03-03
EP1021534B1 (de) 2009-11-25
ES2334727T3 (es) 2010-03-15
US20090025098A1 (en) 2009-01-22
US20070087407A1 (en) 2007-04-19
ATE449847T1 (de) 2009-12-15
AU9363398A (en) 1999-04-27
JP2012125246A (ja) 2012-07-05
JP4198882B2 (ja) 2008-12-17
CA2304796A1 (en) 1999-04-15
EP1021534A1 (de) 2000-07-26
CY1109868T1 (el) 2014-09-10
US20120066779A1 (en) 2012-03-15
JP2001519150A (ja) 2001-10-23
HK1025793A1 (en) 2000-11-24
US20040258694A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
CY1109868T1 (el) Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
NO982062D0 (no) Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav
ATE517922T1 (de) Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
DK1409544T3 (da) Humane DR4-antistoffer og anvendelser deraf
TR199902803T2 (xx) VCAM-1' in te�hisinin daralt�lmas� i�in bile�ikler ve metodlar.
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
BRPI0411078A (pt) ligantes de receptores de canabinóides e seus usos
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
CY1111193T1 (el) Ανθρωπινα cdr-μοσχευμενα αντισωματα και θραυσματα αντισωματων τους
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
TR200000913T2 (tr) Tıbbi maddeler
BRPI0407305A (pt) Ligantes do receptor de canabinóides e seus usos
DK1181319T3 (da) Kimære DR4-antistoffer og anvendelser deraf
DE60033649D1 (de) Verbindungen und therapeutische methoden
MXPA02008239A (es) Gen humano de la esquizofrenia.
TR200100637T2 (tr) Yeni doğal ürün türevleri
TR200103638T2 (tr) IL-8 Reseptör antagonistleri
DE69612056T2 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
DE69514100D1 (de) Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
BR0207327A (pt) Amino derivados de biotina e seus conjugados com agentes quelantes macrocìclicos
PL400309A1 (pl) Kwasy nukleinowe, proteiny oraz przeciwciala BTL-II

Legal Events

Date Code Title Description
8364 No opposition during term of opposition